Not applicableStudy completedNCT04135963What this trial is testingPeople With Multiple Myeloma (MM) in Portugal (CharisMMa-Portugal)Who this might be right forRelapse and/or Refractory Multiple Myeloma Takeda 62
Early research (Phase 1)Looking for participantsNCT06896916What this trial is testingStudy of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma AbbVie 135
Testing effectiveness (Phase 2)Ended earlyNCT01464034What this trial is testingA Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Criterium, Inc. 136
Testing effectiveness (Phase 2)Study completedNCT00708292What this trial is testingA Phase I-Ib/II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 Alone and in Combination With Bortezomib, With or Without Dexamethasone, in Patients With Relapsed or Refractory Multiple Myeloma.Who this might be right forRelapsed or Refractory Multiple Myeloma Novartis Pharmaceuticals 29
Early research (Phase 1)Study completedNCT02948283What this trial is testingMetformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic LeukemiaWho this might be right forAnemiaFatigueFever+10 more City of Hope Medical Center 3
Early research (Phase 1)Looking for participantsNCT06574568What this trial is testingYKST02 in Participants With Relapsed or Refractory Multiple MyelomaWho this might be right forRelapsed or Refractory Multiple Myeloma Excyte Biopharma Ltd 70
Early research (Phase 1)WithdrawnNCT02951117What this trial is testingVenetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer TreatmentWho this might be right forMultiple Myeloma AbbVie
Testing effectiveness (Phase 2)WithdrawnNCT02985333What this trial is testingPaclitaxel,Cyclophosphamide and Dexamethasone for Relapsed or Refractory Multiple MyelomaWho this might be right forRelapse/Refractory Multiple Myeloma Sun Yat-sen University
Testing effectiveness (Phase 2)Study completedNCT01478048What this trial is testingStudy of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Bristol-Myers Squibb 185
Early research (Phase 1)Active Not RecruitingNCT07342114What this trial is testingA Clinical Study to Evaluate the Effects of RO7875913 in Healthy Participants and of RO7875913 With Cevostamab in Participnats With With Relapsed/Refractory Multiple MyelomaWho this might be right forHealthy VolunteersRelapsed Multiple MyelomaRefractory Multiple Myeloma Genentech, Inc. 240
Early research (Phase 1)Study completedNCT02468687What this trial is testingNMP in Relapsed / Refractory MyelomaWho this might be right forMultiple Myeloma Peter MacCallum Cancer Centre, Australia 13
Testing effectiveness (Phase 2)Study completedNCT00833833What this trial is testingMTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Celgene Corporation 259
Early research (Phase 1)Study completedNCT01129193What this trial is testingAR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+64 more Amir Mortazavi 44
Testing effectiveness (Phase 2)UnknownNCT06242249What this trial is testingAnti-BCMA CAR-NK Therapy in Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma, Refractory Shahid Beheshti University of Medical Sciences 10
Testing effectiveness (Phase 2)Study completedNCT02506959What this trial is testingPanobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple MyelomaWho this might be right forPlasma Cell LeukemiaPlasmacytomaRecurrent Plasma Cell Myeloma+1 more M.D. Anderson Cancer Center 83
Early research (Phase 1)Study completedNCT00457782What this trial is testingA Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's LymphomaWho this might be right forMultiple MyelomaChronic Lymphocytic LeukaemiaB-cell Non-Hodgkin's Lymphoma Kyowa Kirin Co., Ltd. 27
Testing effectiveness (Phase 2)Ended earlyNCT02372240What this trial is testingVLX1570 and Dexamethasone in Myeloma PatientsWho this might be right forMultiple Myeloma Vivolux AB 15
Not applicableNo Longer AvailableNCT00423826What this trial is testingUmbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more Barbara Ann Karmanos Cancer Institute
Large-scale testing (Phase 3)Looking for participantsNCT07742215What this trial is testingThe Efficacy and Safety of BCD-248 in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma (AMMADINA)Who this might be right forMyeloma Multiple Biocad 390
Testing effectiveness (Phase 2)Looking for participantsNCT04508790What this trial is testingLeflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple MyelomaWho this might be right forRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma City of Hope Medical Center 29